Incyte (INCY) is a biotechnology company in the Health Care sector. Listed on the NASDAQ, Incyte is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $105.39.
Key Metrics & Risk
Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).
| Metric | Value |
|---|---|
| Latest Price | $105.39 |
| Latest Date | 2026-06-10 |
| Expected Return (Annualized) | 9.19% |
| Risk / Std Dev (Annualized) | 29.33% |
| Sharpe Ratio (rf=4.5%) | 0.16 |
S&P 500 Context
- Sector: Health Care
- Sub-Industry: Biotechnology
- Exchange: NASDAQ
- Index: S&P 500 Component
Risk/Return Profile
The stock shows an annualized expected return of 9.19% with an annualized volatility of 29.33%. The Sharpe ratio of 0.16 (assuming 4.5% risk-free rate) indicates below-average risk-adjusted returns relative to the risk-free rate.
Modern Portfolio Theory Positioning
This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.
Fundamentals
| Metric | Value |
|---|---|
| Market Cap | 21.06B |
| Enterprise Value | 17.08B |
| Trailing P/E | 14.89 |
| Forward P/E | 11.57 |
| Price to Book | 3.75 |
| Price to Sales | 3.93 |
| EV/Revenue | 3.19 |
| EV/EBITDA | 11.03 |
| Profitability | | | Profit Margin | 26.71% | | Operating Margin | 25.55% | | ROE | 30.82% | | ROA | 13.89% |
| Growth | | | Revenue Growth | 20.9% | | Earnings Growth | 83.8% |
| Financial Health | | | Total Revenue | 5.36B | | Total Debt | 0.04B | | Total Cash | 4.02B | | Free Cash Flow | 0.56B | | Operating Cash Flow | 1.52B |
| Price & Technical | | | 52W High | $112.29$ | | 52W Low | $66.74$ | | 50-Day Avg | $96.94$ | | 200-Day Avg | $96.16$ | | Beta | 0.79 | | Shares Outstanding | 0.2B | | Float Shares | 0.17B | | Insider Holdings | 1.88% | | Institutional Holdings | 106.52% | | Short Ratio | 8.37 | | Short % of Float | 9.83% |
| Analyst Targets | | | Target High | $140.0$ | | Target Low | $71.0$ | | Target Mean | $108.83$ | | Target Median | $105.0$ | | # of Analysts | 23 | | Recommendation | buy |
Disclaimer
This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.